The MarketWatch News Department was not involved in the creation of this content. Funding supports expansion of manufacturing and commercial capacity for SemaCyte microcarrier platform CAMBRIDGE, U.K.

The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies. The modular Eveo Cell Therapy Platform is designed to ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

When it succeeds 5G in 2030, the next-gen mobile network will focus on upload speeds, AI, and radar-like “sensing” of vehicles, devices, and people.

Funding to advance proprietary T-cell engager platforms and pipeline of highly differentiated T-cell engager therapies targeting solid tumors and autoimmune diseases Financing co-led by multiple ...

SINGAPORE--(BUSINESS WIRE)-- ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer immunotherapies, today announced an ...

Explore how neuromorphic chips and brain-inspired computing bring low-power, efficient intelligence to edge AI, robotics, and IoT through spiking neural networks and next-gen processors. Pixabay, ...

Silex Systems develops the laser-based isotope separation technology, which could be valuable for the U.S. nuclear renaissance. The company missed benefiting from the DoE's investment awards but ...